Nicotinamide riboside is uniquely and orally bioavailable in mice and humans
Open accessThe DOI matches its Crossref record; 57 of the 57 references it cites were found in a registry or an index.
Abstract
Nicotinamide riboside (NR) is in wide use as an NAD + precursor vitamin. Here we determine the time and dose-dependent effects of NR on blood NAD + metabolism in humans. We report that human blood NAD + can rise as much as 2.7-fold with a single oral dose of NR in a pilot study of one individual, and that oral NR elevates mouse hepatic NAD + with distinct and superior pharmacokinetics to those of nicotinic acid and nicotinamide. We further show that single doses of 100, 300 and 1,000 mg of NR produce dose-dependent increases in the blood NAD + metabolome in the first clinical trial of NR pharmacokinetics in humans. We also report that nicotinic acid adenine dinucleotide (NAAD), which was not thought to be en route for the conversion of NR to NAD + , is formed from NR and discover that the rise in NAAD is a highly sensitive biomarker of effective NAD + repletion.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures








Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“NAM, in contrast, is a well reported and widely used sirtuin inhibitor31 and has been recently shown to inhibit NAD+-consuming activities in vivo24.”
From NRK1 controls nicotinamide mononucleotide and nicotinamide riboside metabolism in mammalian cells (2016) · cites this paper as [24]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“In another study, NAAD was not detected in human blood prior to NR supplementation, while there was a ∼2,900% increase in NAAD baseline in healthy individuals taking single doses of up to 1 g NR (100, 300, and 1000 mg) [63].”
From NAD+ Precursors Nicotinamide Mononucleotide (NMN) and Nicotinamide Riboside (NR): Potential Dietary Contribution to Health (2023) · cites this paper as [63]
The cited source says what the claim attributes to it.
In the citing paper
“It is still unclear why NR administration increases NAD+ levels more than NAM and NA treatment [63], while NMN and NAM administration showed no difference in NAD levels in blood and liver [90].”
From NAD+ Precursors Nicotinamide Mononucleotide (NMN) and Nicotinamide Riboside (NR): Potential Dietary Contribution to Health (2023) · cites this paper as [63]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“However, by LC-tandem MS and with the use of internal standards, the baseline concentrations of hepatic NMN and NAD+ were determined to be ∼2 and ∼1,000 pmol mg−1, respectively, rising to ∼10 and ∼4,000 pmol mg−1, respectively, 6 h after oral gavage of 185 mg kg−1 NR24.”
From NRK1 controls nicotinamide mononucleotide and nicotinamide riboside metabolism in mammalian cells (2016) · cites this paper as [24]
The cited source says what the claim attributes to it.
In the citing paper
“This concept was established by a recent study in which orally administered equimolar NAM, NR and NA produced unique effects on hepatic NAD+ metabolism through distinct biosynthetic routes24.”
From NRK1 controls nicotinamide mononucleotide and nicotinamide riboside metabolism in mammalian cells (2016) · cites this paper as [24]
2 more claims about this paper
Create a free account to see every claim other papers make about this one.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Braidy, N., Poljak, A., Grant, R., Jayasena, T., Mansour, H., Chan‐Ling, T., Guillemin, G. J., Smythe, G. A., & Sachdev, P. S. (2013) · Biogerontology · doi:10.1007/s10522-013-9489-5 · Cited by 126
RetractedDose translation from animal to human studies revisited.
Reagan‐Shaw, S., Nihal, M., & Ahmad, N. (2008) · The FASEB Journal · doi:10.1096/fj.07-9574lsf · Cited by 6,524
Cantó, C., Menzies, K. J., & Auwerx, J. (2015) · Cell Metabolism · doi:10.1016/j.cmet.2015.05.023 · Cited by 1,648
Recent progress in the biology and physiology of sirtuins
Finkel, T., Deng, C.-X., & Mostoslavsky, R. (2009) · Nature · doi:10.1038/nature08197 · Cited by 1,484
Gomes, A. P., Price, N. L., Ling, A. J. Y., Moslehi, J. J., Montgomery, M. K., Rajman, L., White, J. P., Teodoro, J. S., Wrann, C. D., Hubbard, B. P., et al. (2013) · Cell · doi:10.1016/j.cell.2013.11.037 · Cited by 1,482
NAD+ and sirtuins in aging and disease
Imai, S.-I., & Guarente, L. (2014) · Trends in Cell Biology · doi:10.1016/j.tcb.2014.04.002 · Cited by 1,481
Yoshino, J., Mills, K. F., Yoon, M. J., & Imai, S.-I. (2011) · Cell Metabolism · doi:10.1016/j.cmet.2011.08.014 · Cited by 1,340
NAD + in aging, metabolism, and neurodegeneration
Verdin, E. (2015) · Science · doi:10.1126/science.aac4854 · Cited by 1,319
NAD + repletion improves mitochondrial and stem cell function and enhances life span in mice
Zhang, H., Ryu, D., Wu, Y., Gariani, K., Wang, X., Luan, P., D’Amico, D., Ropelle, E. R., Lutolf, M. P., Aebersold, R., et al. (2016) · Science · doi:10.1126/science.aaf2693 · Cited by 1,255
Cantó, C., Houtkooper, R. H., Pirinen, E., Youn, D. Y., Oosterveer, M. H., Cen, Y., Fernandez-Marcos, P. J., Yamamoto, H., Andreux, P. A., Cettour-Rose, P., et al. (2012) · Cell Metabolism · doi:10.1016/j.cmet.2012.04.022 · Cited by 1,238
Research works printed but not linked: 1
- Altman, L. K. Who Goes First: The Story of Self-experimentation in Medicine University of California Press (1987).
Cited by
Items 401–500 of 696
Palmer, R. D., Elnashar, M. M. M., & Vaccarezza, M. (2021) · Aging Medicine · doi:10.1002/agm2.12170 · Cited by 16
“However, NADP is more limited to biosynthetic pathways and redox protective roles.7 Further discoveries were made by other research teams such as when Lee et al. (1989)8 discovered a novel NAD+ metabolite in 1989, cyclic ADP- ribose.”
ResultInfluentialRedeuil, K. M., Vulcano, J., Prencipe, F. P., Bénet, S., Campos-Giménez, E., & Meschiari, M. (2019) · Journal of Chromatography B · doi:10.1016/j.jchromb.2019.01.028 · Cited by 17
Podyacheva, E., & Toropova, Y. G. (2021) · Nutrients · doi:10.3390/nu13103435 · Cited by 17
“[35] C57Bl/6J mice, 12-week-old male; 6–8-week-old 185 mg/kg; 500 mg/kg 1 week; 6 days diet; IP The increase in NAAD is a highly sensitive biomarker of effective NAD+ repletion.”
BackgroundLoomba, M., Bansal, S., Singh, K. K., Mishra, P. K., Ghosh, S., Raghunath, M., Mishra, A. K., & Sinha, J. K. (2025) · Nutrients · doi:10.3390/nu17213493 · Cited by 15
“These agents should be evaluated within lifestyle-anchored trials rather than used as first-line, stand-alone strategies [36,37].”
Sirtuin1 in vascular endothelial function, an overview
Kumar, J., & Kumar, S. (2021) · Epigenetics · doi:10.1080/15592294.2021.1975936 · Cited by 14
Pan, W., Tsokos, M., Scherlinger, M., Li, W., & Tsokos, G. C. (2024) · Cell Reports · doi:10.1016/j.celrep.2024.114379 · Cited by 16
Shoji, M., Kato, H., Koshizaka, M., Kaneko, H., Baba, Y., Ishikawa, T., Teramoto, N., Kinoshita, D., Yamaguchi, A., Maeda, Y., et al. (2025) · Aging Cell · doi:10.1111/acel.70093 · Cited by 18
“While NR has been shown to elevate NAD + levels in human blood within hours (Trammell et al. 2016b), a previous crossover study reported an anti-inflammatory effect of NR following a 21-day administration period with a subsequent 2–3 week washout phase (Elhassan et al. 2019).”
Cross-talk in NAD+ metabolism: insights from Saccharomyces cerevisiae
Raj, C. J. T., & Lin, S.-J. (2019) · Current Genetics · doi:10.1007/s00294-019-00972-0 · Cited by 13
Mass Spectrometry in Advancement of Redox Precision Medicine
Chen, X., Lee, J., Wu, H., Tsang, A. W., & Furdui, C. M. (2019) · Advances in experimental medicine and biology · doi:10.1007/978-3-030-15950-4_19 · Cited by 12
Tran, T., Pencina, K. M., Schultz, M. B., Li, Z., Ghattas, C., Lau, J., Sinclair, D. A., & Montano, M. A. (2022) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/qai.0000000000002852 · Cited by 14
Self-citationDamschroder, D., Perez, R. Z., Richardson, K., Vaz, F. M., Houtkooper, R. H., & Wessells, R. J. (2022) · Disease Models & Mechanisms · doi:10.1242/dmm.049279 · Cited by 13
Birkisdóttir, M. B., van Galen, I., Brandt, R. M. C., Barnhoorn, S., van Vliet, N., van Dijk, C., Nagarajah, B., Imholz, S., van Oostrom, C. T., Reiling, E., et al. (2022) · Frontiers in Aging · doi:10.3389/fragi.2022.1005322 · Cited by 15
Chubanava, S., & Treebak, J. T. (2023) · Experimental Gerontology · doi:10.1016/j.exger.2023.112109 · Cited by 17
“has become the most widely studied NAD precursor (Trammell et al., 2016).”
BackgroundThe use of Nicotinamide and Nicotinamide riboside as an adjunct therapy in the treatment of glaucoma
Silva, S. G. N. E., Occhiutto, M. L., & Costa, V. P. (2023) · European Journal of Ophthalmology · doi:10.1177/11206721231161101 · Cited by 14
Wang, L., Liu, B., Liu, Y., Sun, Y. R., Liu, W., Yu, D., & Zhao, Z. K. (2019) · Organic Letters · doi:10.1021/acs.orglett.9b00935 · Cited by 13
The 4 D’s of Pellagra and Progress
Williams, A. C., & Hill, L. J. (2020) · International Journal of Tryptophan Research · doi:10.1177/1178646920910159 · Cited by 15
“[228] [229] [230] [231] Increasing fertility and sexual selection for not only physical but behavioural, cognitive and language prowess as secondary 'ornaments' is marked with many X-linked genes involved with both fertility and cognition.”
BackgroundRisks and rewards of targeting NAD+ homeostasis in the brain
Li, C., & Wu, L. E. (2021) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2021.111545 · Cited by 14
Dierickx, P., Carpenter, B. J., Celwyn, I. J., Kelly, D. P., Baur, J. A., & Lazar, M. A. (2022) · Frontiers in Molecular Medicine · doi:10.3389/fmmed.2022.887733 · Cited by 14
Xia, S., & Chiang, A. (2009) · Europe PMC (PubMed Central) · Cited by 13
Importance of NAD+ Anabolism in Metabolic, Cardiovascular and Neurodegenerative Disorders
Helman, T. J., & Braidy, N. (2022) · Drugs & Aging · doi:10.1007/s40266-022-00989-0 · Cited by 15
Potential Therapeutic Effects of NAMPT-Mediated NAD Biosynthesis in Depression In Vivo
Wang, J., Sun, R., Xia, L., Zhu, X., Zhang, Q., & Ye, Y. (2022) · Brain Sciences · doi:10.3390/brainsci12121699 · Cited by 14
“The NR biosynthetic pathway is distinctly and incredibly effective in rodents and humans [25].”
BackgroundNAD + depletion is central to placental dysfunction in an inflammatory subclass of preeclampsia
Jahan, F., Vasam, G., Cariaco, Y., Nik-Akhtar, A., Green, A. E., Menzies, K. J., & Bainbridge, S. A. (2024) · Life Science Alliance · doi:10.26508/lsa.202302505 · Cited by 12
“To avoid unnecessary delays in the acceptance and publication of your paper, please read the following information carefully.”
Cryptic phosphoribosylase activity of NAMPT restricts the virion incorporation of viral proteins
Feng, S., Xie, N., Liu, Y., Qin, C., Savas, A. C., Wang, T., Li, S., Rao, Y., Shambayate, A., Chou, T., et al. (2024) · Nature Metabolism · doi:10.1038/s42255-024-01162-0 · Cited by 12
“To restore NAD + , 400 mg kg −1 of NR was supplemented daily by intraperitoneal injection 41 .”
Self-citationHe, Y., Lipa, K. E., Alexander, P. G., Clark, K. L., & Lin, H. (2022) · Biology · doi:10.3390/biology11070996 · Cited by 16
Higashida, H., Furuhara, K., Lopatina, O. L., Gerasimenko, M., Hori, O., Hattori, T., Hayashi, Y., Михайлович, Ч. С., Shabalova, A. A., Salmina, A. B., et al. (2022) · Frontiers in Neuroscience · doi:10.3389/fnins.2022.858070 · Cited by 14
Zhou, M., Li, Y., Che, H., Sun, Y., Wang, S., Zhan, Y., Cai, D., & Chen, S. (2023) · ACS Sustainable Chemistry & Engineering · doi:10.1021/acssuschemeng.2c07271 · Cited by 12
Nicotinamide Adenine Dinucleotide (NAD + )-Dependent Signaling in Neurological Disorders
Bresque, M., Esteve, D., Pehar, M., & Vargas, M. R. (2023) · Antioxidants and Redox Signaling · doi:10.1089/ars.2023.0241 · Cited by 13
“On the contrary, the apparent safety and simplicity of using NAD + precursors as a boosting strategy (Airhart et al., 2017; de la Rubia et al., 2019; Del-linger et al., 2017; Trammell et al., 2016) have emerged as the preferred therapeutic strategy.”
U-Din, M., de Mello, V. D., Tuomainen, M. H., Raiko, J. R. H., Niemi, T. S., Fromme, T., Klåvus, A., Gautier, N., Haimilahti, K., Lehtonen, M., et al. (2023) · Cell Reports · doi:10.1016/j.celrep.2023.113131 · Cited by 22
“87 Our study also does not provide NAD + concentration data in human BAT biopsy samples, rather only tryptophan because of the utilization of a non-targeted me-tabolomics approach.”
BackgroundThe elusive NMN transporter is found
Wu, L. E., & Sinclair, D. A. (2018) · Nature Metabolism · doi:10.1038/s42255-018-0015-6 · Cited by 14
Marinescu, A. G., Chen, J., Holmes, H. E., Guarente, L., Mendes, O. R., Morris, M., & Dellinger, R. W. (2020) · International Journal of Toxicology · doi:10.1177/1091581820927406 · Cited by 12
Self-citationNAD+ metabolism and retinal degeneration (Review)
Pîrvu, A. S., Andrei, A. M., Stănciulescu, E. C., Baniţă, I. M., Pisoschi, C. G., Jurja, S., & Ciuluvica, R. C. (2021) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2021.10102 · Cited by 13
“7‐fold rise in blood NAD+ after one dose of NR (24).”
BackgroundPodyacheva, E., N.Yu., N., Vsevolod, V. A., Mukhametdinova, D. V., Goncharova, I., Александровна, З. И., Sviridov, E. E., Martynov, M. O., Osipova, S. A., & Toropova, Y. G. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232113096 · Cited by 13
“Drug dosages were determined empirically, considering existing literature data [9,22,40,41,55] as well as our own unpublished data.”
BackgroundMethodSirtuins, Healthspan, and Longevity in Mammals
Giblin, W., & Lombard, D. B. (2015) · Elsevier eBooks · doi:10.1016/b978-0-12-411596-5.00003-4 · Cited by 12
Gaare, J. J., Dölle, C., Brakedal, B., Brügger, K., Haugarvoll, K., Nido, G. S., & Tzoulis, C. (2023) · iScience · doi:10.1016/j.isci.2023.106278 · Cited by 12
Metcalfe, M., David, B. T., Langley, B. C., & Hill, C. E. (2023) · Experimental Neurology · doi:10.1016/j.expneurol.2023.114479 · Cited by 12
Zhang, D., Yau, L., Bai, L., Tong, T., Cao, K., Yan, T., Zeng, L., & Jiang, Z. (2023) · Journal of Pharmacy and Pharmacology · doi:10.1093/jpp/rgad090 · Cited by 11
Hove, J. L. K. V., Friederich, M. W., Hock, D. H., Stroud, D. A., Caruana, N. J., Christians, U., Schniedewind, B., Michel, C. R., Reisdorph, R. M., Gonzalez, E. D. J. L., et al. (2024) · Mitochondrion · doi:10.1016/j.mito.2024.101905 · Cited by 13
Self-citationXu, Y., Lu, A., Guan, X., Ying, T., Pan, J., Tan, M., & Lu, J. (2024) · Food Frontiers · doi:10.1002/fft2.511 · Cited by 13
Advancing antihypertensive drug development
Pu, F., Liu, Y., Ahmed, F. Z., Wang, X., Green, D., & Zhang, H. (2025) · British Journal of Pharmacology · doi:10.1111/bph.70063 · Cited by 18
“Previous studies demonstrated that a signal dose of NR effectively elevates blood NAD + levels in a dose-dependent manner (Conze et al., 2019; Trammell et al., 2016).”
Circadian cardiac NAD+ metabolism, from transcriptional regulation to healthy aging
Carpenter, B. J., & Dierickx, P. (2022) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00239.2022 · Cited by 13
Saito, Y., Sato, K., Jinno, S., Nakamura, Y., Nobukuni, T., Ogishima, S., Mizuno, S., Koshiba, S., Kuriyama, S., Ohneda, K., et al. (2023) · Nutrients · doi:10.3390/nu16010145 · Cited by 10
“The roles of the NAD precursors nicotinamide (NAM) and nicotinic acid (NA) have long been studied, but nicotinamide riboside (NR) and NMN have recently received attention as more-effective NAD precursors for raising NAD levels than NA and NAM [18,19].”
BackgroundResultMetabolism and Receptor Mechanisms of Niacin Action
Boronovskiy, S. E., Сергеевна, К. В., & Nartsissov, Y. R. (2024) · Cell and Tissue Biology · doi:10.1134/s1990519x23700025 · Cited by 13
“…of NR at doses of 250 and 500 mg/kg leads to a significant increase in the NAM pool in plasma, liver (Giroud-Gerbetant et al., 2019) and heart (Trammell et al., 2016), and when PNP activity is suppressed high levels of riboside are maintained in the blood, kidneys and liver, which generally…”
PPARγ-Coactivator-1α, Nicotinamide Adenine Dinucleotide and Renal Stress Resistance
Mehr, A. P., & Parikh, S. M. (2017) · The Nephron journals/Nephron journals · doi:10.1159/000471895 · Cited by 13
Supplemental Nicotinic Acid Elevates NAD+ Precursors in the Follicular Fluid of Mares
Pollard, C., Gibb, Z., Clulow, J., Ruiz, A. J., Sheridan, A. R., Bahrami, M. A., Swegen, A., & Grupen, C. G. (2022) · Animals · doi:10.3390/ani12111383 · Cited by 11
“NaAD is considered the most sensitive biomarker for NAD+ metabolism [41] and was found to remain elevated in the plasma of mares for at least 22 h following the oral administration of a single supraphysiological dose of 5 g of NA [25].”
BackgroundLin, Y., Zeidan, R. S., Lapierre, S., Costello, H. M., Anton, S. D., Buford, T. W., Christou, D. D., Gumz, M. L., Leeuwenburgh, C., Martens, C. R., et al. (2025) · GeroScience · doi:10.1007/s11357-025-01815-2 · Cited by 14
“A dose of 1000 mg/ day was reported safe and upregulated blood NAD metabolites [20], and a 6-week supplementation period reduced SBP and arterial stiffness in normotensive middle-aged and older adults [19].”
Self-citationDoig, C. L., Zielinska, A. E., Fletcher, R. S., Oakey, L. A., Elhassan, Y., Garten, A., Cartwright, D., Heising, S., Alsheri, A., Watson, D. G., et al. (2020) · Skeletal Muscle · doi:10.1186/s13395-019-0216-z · Cited by 13
Innovations and Emerging Therapies to Combat Renal Cell Damage: NAD + As a Drug Target
Manrique‐Caballero, C. L., Kellum, J. A., Gómez, H., Franco, F., Giacchè, N., & Pellicciari, R. (2021) · Antioxidants and Redox Signaling · doi:10.1089/ars.2020.8066 · Cited by 11
“Furthermore, some studies described it as the ‘‘most potent’’ therapy when it comes to replenishing NAD + reserves (13, 108), making NR a safe and viable therapy with high feasibility of implementation (34).”
Supplementation with NAD+ Precursors for Treating Alzheimer’s Disease: A Metabolic Approach
Alghamdi, M. A., & Braidy, N. (2024) · Journal of Alzheimer s Disease · doi:10.3233/jad-231277 · Cited by 14
“Higher levels of NMN, NAMN, NAM, NAAD, NAD+ and NADP+ were reported following oral gavage of NR compared to oral NAM which suggests increased activation of the NAD+ biosynthesis pathway following oral supplementation with NR [61].”
InfluentialDuan, H., Zhang, R., Asikaer, A., Pan, L., Wang, S., Huang, K., Lou, D., Wang, Y., Lin, Z., & Shen, Y. (2025) · International Immunopharmacology · doi:10.1016/j.intimp.2025.114620 · Cited by 9
Ren, H., Wang, J., Liu, J., Zhang, Z., Wang, L., & Wei, F. (2025) · Progress in Orthodontics · doi:10.1186/s40510-025-00566-2 · Cited by 9
“Group D was given intraperitoneal injections of 100 mg/kg NMN (Beyotime Biotechnology, Shanghai, China) solution in normal saline every 2 days [17].”
Arizono, I., Fujita, N., Tsukahara, C., Sase, K., Sekine, R., Jujo, T., Otsubo, M., Tokuda, N., & Kitaoka, Y. (2023) · Current Issues in Molecular Biology · doi:10.3390/cimb45090449 · Cited by 11
“Nicotinamide riboside (NR) is available as a nicotinamide adenine dinucleotide + (NAD + ) precursor supplement and was reported to upregulate serum NAD + levels in humans [1].”
BackgroundAssociation between NAD + levels and anaemia among women in community‐based study
Yang, F., Zhang, X., Hu, F., Yu, Y., Luo, L., Deng, X., Zhao, Y., Pan, B., Zheng, J., Qiu, Y., et al. (2022) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.17281 · Cited by 8
Could NAMPT inhibition become a potential treatment option in hepatocellular carcinoma?
Garten, A., Schuster, S., & Penke, M. (2017) · Expert Review of Anticancer Therapy · doi:10.1080/14737140.2017.1298447 · Cited by 9
“or intermediates did not show obvious toxicity or deleterious effects and increased NAD levels in mouse liver [18,19].”
BackgroundNAD+ metabolism and eye diseases: current status and future directions
Liu, S., & Zhang, W. (2023) · Molecular Biology Reports · doi:10.1007/s11033-023-08692-y · Cited by 7
“In recent years, researchers have discovered that NR has a higher conversion rate to NAD + compared to NAM [ 96], and shows a strong protective effect on RGCs and photore - ceptors [60 , 62].”
BackgroundNAD in pathological cardiac remodeling: Metabolic regulation and beyond
Norambuena‐Soto, I., Deng, Y., Brenner, C., Lavandero, S., & Wang, Z. V. (2024) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2024.167038 · Cited by 15
Self-citationXie, X., Kong, Q., Chen, Y., Yang, Z., Wu, Z., Xiao, Y., Chen, Y., Yu, Z., Luo, X., & Qu, W. (2024) · Journal of Neurorestoratology · doi:10.1016/j.jnrt.2024.100111 · Cited by 8
CD38 mediates nicotinamide mononucleotide base exchange to yield nicotinic acid mononucleotide
Madawala, R. J., Banks, J. L., Hancock, S. E., Quek, L., Turner, N. A., & Wu, L. E. (2025) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2025.108248 · Cited by 9
“NaAD) following double-labeled NR treatment (25).”
InfluentialTeppa-Garrán, A., Pérez-Peña, E., Sobrevía, L., & Marín, R. (2025) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2025.167987 · Cited by 10
Yu, Q., Li, L., Yu, S., Han, J., Cheng, Q., Cui, Z., Chen, H., Li, M., & Lu, Z. (2025) · Neurochemical Research · doi:10.1007/s11064-025-04490-z · Cited by 9
Yang, X., Huang, K., Qin, J., Cui, X., Zhang, Z., Huang, Q., Wu, Y., Lei, X., & Zhang, S. (2025) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2025.09.019 · Cited by 8
Berven, H., Svensen, M., Eikeland, H., Tvedten, N., Sheard, E., Geijerstam, S. A. A., Søgnen, M., McCann, A., Arnsten, L., Arseth, O., et al. (2026) · iScience · doi:10.1016/j.isci.2026.114764 · Cited by 11
“25,32,34,40 On the other hand, an elevated use of NAD + also increases the main substrate of human NAD synthesis, nicotinamide, which is available for recycling and may thus contribute to an extended maintenance of the elevated NAD levels.”
InfluentialThe evolution of personalized medicine: publications review
Rykov, M. Y. (2022) · Problems of Social Hygiene Public Health and History of Medicine · doi:10.32687/0869-866x-2022-30-6-1211-1219 · Cited by 11
Niacinamide and Neuroprotection: The Glaucoma Holy Grail
Bhartiya, S. (2023) · JOURNAL OF CURRENT GLAUCOMA PRACTICE · doi:10.5005/jp-journals-10078-1390 · Cited by 8
NR Supplementation During Lactation: Benefiting Mother and Child
Yang, D., & Wan, Y. (2019) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2019.02.004 · Cited by 8
Nutraceuticals for Promoting Longevity
Pavlović, I., Khateb, S., Milisav, I., & Mahajna, J. A. (2020) · Current Nutraceuticals · doi:10.2174/2665978601666200213121512 · Cited by 9
EFSA Panel on Nutrition, N. F. A. F. A. (., Turck, D., Bohn, T., Castenmiller, J. J. M., Henauw, S. D., Hirsch‐Ernst, K. I., Maciuk, A., Mangelsdorf, I., McArdle, H. J., Naska, A., et al. (2021) · EFSA Journal · doi:10.2903/j.efsa.2021.6843 · Cited by 10
Autophagy-inducing nutritional interventions in experimental and clinical oncology
Hofer, S. J., Kroemer, G., & Kepp, O. (2022) · International review of cytology · doi:10.1016/bs.ircmb.2022.08.003 · Cited by 10
Hamity, M. V., Kolker, S. J., Hegarty, D. M., Blum, C., Langmack, L., Aicher, S. A., & Hammond, D. L. (2022) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.63.1.38 · Cited by 8
Insulin and glycolysis dependency of cardioprotection by nicotinamide riboside
Xiao, Y., Wang, Q., Zhang, H., Nederlof, R., Bakker, D., Siadari, B. A., Wesselink, M. W., Preckel, B., Weber, N. C., Hollmann, M. W., et al. (2024) · Basic Research in Cardiology · doi:10.1007/s00395-024-01042-4 · Cited by 10
Dynamics of blood NAD and glutathione in health, disease, aging, and under NAD+-booster treatment
Euro, L., Haimilahti, K., Jansson, S., Forsström, S., Buzková, J., & Suomalainen, A. (2026) · Redox Biology · doi:10.1016/j.redox.2026.104343 · Cited by 13
“The efficacy of these NAD + -boosters in elevating NAD + levels has been extensively studied in model systems and in humans [16,17,19,21,22].”
Sun, J.-Y., Wang, Z., Xu, W., & Zhao, J. (2025) · Biochemical Pharmacology · doi:10.1016/j.bcp.2025.117050 · Cited by 8
Venkatesan, S., Comi, C., Marchi, F. D., Esposito, T., Gramaglia, C. M., Smirne, C., Pour, M. M. O., Pirisi, M., Vaschetto, R., Zeppegno, P., et al. (2026) · Biomolecules · doi:10.3390/biom16010117 · Cited by 10
“These compounds improve metabolic and cognitive parameters in aging and neurodegeneration models and show early benefits in human metabolic studies, though trauma-specific trials are absent [90].”
A human liver organoids-on-chip for the assessment of drug-induced liver injury
Chen, X., 鲍方, Liu, J., Wang, Y., Tao, T., Zhang, G., & Qin, J. (2026) · BMC Pharmacology and Toxicology · doi:10.1186/s40360-025-01074-z · Cited by 12
“For a long time, preclinical drug research has primarily relied on 2D cell culture systems and animal models, which have provided valuable insights into drug toxicity, efficacy, and pharmacokinetics [4–8].”
Biotechnological production of reduced and oxidized NAD+ precursors
Perez, R. Z., García-Saura, A. G., Scantlebery, A. M. L., Schomakers, B. V., Rabadán-Ros, R., van Weeghel, M., Houtkooper, R. H., & Sánchez‐Ferrer, Á. (2023) · Food Research International · doi:10.1016/j.foodres.2023.112560 · Cited by 7
Turconi, G., Alam, F., SenGupta, T., Pirnes-Karhu, S., Olfat, S., Schmidt, M. S., Mätlik, K., Montaño-Rodriguez, A., Heiskanen, V., Garton, D. R., et al. (2024) · Heliyon · doi:10.1016/j.heliyon.2024.e34355 · Cited by 8
“S3C) [41].”
Self-citationCardoso, D., Guilbert, S. M., Guigue, P., Carabalona, A., Harhouri, K., Peccate, C., Tournois, J., Guesmia, Z., Ferreira, L., Bartoli, C., et al. (2024) · Cell Death and Disease · doi:10.1038/s41419-024-07078-7 · Cited by 9
“All animal studies were approved by the French Ministry of Health at the Marseille medical genetics institute for the Care and Use of Experimental Animals [2019070912126767-V2 #21407].”
BackgroundNicotinamide riboside–amino acid conjugates that are stable to purine nucleoside phosphorylase
Hayat, F., & Migaud, M. E. (2020) · Organic & Biomolecular Chemistry · doi:10.1039/d0ob00134a · Cited by 9
Self-citationA Bloody Feast—Nutritional Regulation of Hematopoiesis
Ussishkin, N., & Nachmani, D. (2023) · Experimental Hematology · doi:10.1016/j.exphem.2023.08.004 · Cited by 8
Comment on “Nicotinamide mononucleotide increases muscle insulin sensitivity in prediabetic women”
Brenner, C. (2021) · Science · doi:10.1126/science.abj1696 · Cited by 7
“However, the safety and availability of NR as a nutritional supplement (3, 4) have driven dozens of groups worldwide to test potential activities of NR in diseases and conditions of metabolic stress.”
BackgroundSelf-citationHawkins, J., Idoine, R., Kwon, J., Shao, A. E., Dunne, E., Hawkins, E. M., Dawson, K., & Nkrumah-Elie, Y. M. (2024) · medRxiv · doi:10.1101/2024.06.06.24308565 · Cited by 9
“…been described to be safe and effective in raising NAD+ and has shown promise against neurodegenerative conditions and other age-related disorders (Samuel A. J. Trammell et al. , 2016; Elhassan et al. , 2019; Brakedal et al. , 2022; Berven et al. , 2023; Biţă et al. , 2023) In spite of the…”
BackgroundZhang, J., Poon, E. T., & Wong, S. H. (2024) · Critical Reviews in Food Science and Nutrition · doi:10.1080/10408398.2024.2387324 · Cited by 8
Miranda, E. R., Varshney, P., Mazo, C. E., Shadiow, J., Ludlow, A. T., & Haus, J. M. (2024) · Redox Biology · doi:10.1016/j.redox.2024.103300 · Cited by 6
NAD+ enhancers as therapeutic agents in the cardiorenal axis
Marin-Blazquez, M., Rovira, J., Ramírez-Bajo, M. J., Perez, R. Z., & Rabadán-Ros, R. (2024) · Cell Communication and Signaling · doi:10.1186/s12964-024-01903-4 · Cited by 7
The protection of nicotinamide riboside against diabetes mellitus-induced bone loss via OXPHOS
Gao, J., Meng, X., Yang, X., Xie, C., Tian, C., Gong, J., Zhang, J., Dai, S., & Gao, T. (2025) · Bone · doi:10.1016/j.bone.2025.117411 · Cited by 8
Manickam, R., Santhana, S., Xuan, W., Bisht, K. S., & Tipparaju, S. M. (2025) · Canadian Journal of Physiology and Pharmacology · doi:10.1139/cjpp-2024-0400 · Cited by 11
Dettlaff‐Pokora, A., & Świerczyński, J. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26094463 · Cited by 6
“Moreover, the aforementioned compounds can increase 2PY and 4PY levels [18,68,71,72].”
Hamad, R. S., Hasan, W. A., Elmorsy, E. A., Farrag, A. A. M., Abdelaziz, M. A., Alalawy, A. I., Parveen, H., Mukhtar, S., Alsirhani, A. M., ALrashidi, A. A., et al. (2025) · International Immunopharmacology · doi:10.1016/j.intimp.2025.115852 · Cited by 6
Personalized medicine: current trends and prospects
Dolgopolov, I. S., & Rykov, M. Y. (2022) · Rossiyskiy Vestnik Perinatologii i Pediatrii (Russian Bulletin of Perinatology and Pediatrics) · doi:10.21508/1027-4065-2022-67-4-14-21 · Cited by 6
Hepatic steatosis induced by nicotine plus Coca-Cola™ is prevented by nicotinamide riboside (NR)
Rivera, J. C., Espinoza‐Derout, J., Hasan, K. M., Molina-Mancio, J., Martínez, J., Lao, C. J., Lee, M. L., Lee, D. L., Wilson, J. B., Sinha‐Hikim, A. P., et al. (2024) · Frontiers in Endocrinology · doi:10.3389/fendo.2024.1282231 · Cited by 8
“The salvage pathway can be supplemented by exogenous precursors (23, 24).”
BackgroundWatanabe, M., & Sasaki, N. (2024) · Genes · doi:10.3390/genes15070894 · Cited by 7
Nishida, S., Ishima, T., Iwami, D., Nagai, R., & Aizawa, K. (2025) · Antioxidants · doi:10.3390/antiox14010062 · Cited by 6
“In this study, NMN and NAM, metabolites related to the NAD + salvage pathway [58,59], were also examined.”
Advances in pharmacological interventions of aging in mice
Qian, M., & Liu, B. (2019) · Translational Medicine of Aging · doi:10.1016/j.tma.2019.11.002 · Cited by 6
Fluharty, N. T., & Brenner, C. (2020) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/nqaa109 · Cited by 7
“With the world clamoring for orally active obesity interventions and with human safety established for NR (6, 7),”
BackgroundSelf-citationDerivatives of Isonicotinic Acid as New Efficient Systemic Acquired Resistance (SAR) Inducers
Czerwoniec, P., Lewandowski, P., & Śmiglak, M. (2020) · ChemistrySelect · doi:10.1002/slct.202002818 · Cited by 6
New Crystalline Salts of Nicotinamide Riboside as Food Additives
Schabert, G., Haase, R. G., Parris, J., Pala, L., Hery-Barranco, A., Spingler, B., & Spitz, U. P. (2021) · Molecules · doi:10.3390/molecules26092729 · Cited by 8
NAD+ Acts as a Protective Factor in Cellular Stress Response to DNA Alkylating Agents
Ruszkiewicz, J. A., Papatheodorou, Y., Jäck, N., Melzig, J., Eble, F., Pirker, A., Thomann, M., Haberer, A., Rothmiller, S., Bürkle, A., et al. (2023) · Cells · doi:10.3390/cells12192396 · Cited by 6
“3-fold increase of NAD+ levels in peripheral blood mononuclear cells (PBMCs) at 4 h post-ingestion [25].”
BackgroundResultInfluentialCardoso, D., Barthélémy, I., Blot, S., & Muchir, A. (2023) · Skeletal Muscle · doi:10.1186/s13395-023-00328-w · Cited by 7
“Recent studies indicate that dietary supplementation with NR protects against high-fat-diet-induced obesity [6] while improving hepatic function and protecting against diabetic neuropathy [32].”
BackgroundDeBartolo, D., Arnold, F. J., Liu, Y., Molotsky, E., Tang, H., & Merry, D. E. (2024) · JCI Insight · doi:10.1172/jci.insight.178048 · Cited by 8
“This remains a tantalizing therapeutic prospect, as human trials have already determined that chronic NR supplementation is well tolerated in older adults (81) and effectively stimulates NAD + metabolism in a dose-dependent manner (82).”
BackgroundNicotinamide riboside alleviates cisplatin-induced peripheral neuropathy via SIRT2 activation
Acklin, S., Sadhukhan, R., Du, W., Patra, M., Cholia, R. P., & Xia, F. (2022) · Neuro-Oncology Advances · doi:10.1093/noajnl/vdac101 · Cited by 6
Nicotinamide protects against diabetic kidney disease through regulation of Sirt1
Yang, Y., Huang, J., Xie, L., Wang, Y., Guo, S., Wang, M., Shao, X., Liu, W., Wang, Y., Li, Q., et al. (2024) · Endocrine · doi:10.1007/s12020-024-03721-7 · Cited by 5
“In terms of supplementation with NAD + precursors, nicotinamide mononucleotide (NMN) and nicotinamide riboside (NR) have fewer adverse reactions, and can ef fi ciently enhance NAD + biosynthesis [9] to improve various metabolic abnormalities.”
Background
Metadata
- Authors
- Trammell, S. A. J., Schmidt, M. S., Weidemann, B. J., Redpath, P., Jaksch, F., Dellinger, R. W., Li, Z., Abel, E. D., Migaud, M. E., & Brenner, C.
- Affiliations
- University of Iowa (US)
- Queen's University Belfast (GB)
- ChromaDex (United States) (US)
- Corresponding author
- Brenner, Charles
- ORCID
- Venue
- Nature Communications
- Published
- 2016-10-10
- Volume
- 7
- Issue
- 1
- Pages
- 12948-12948
- ISSN
- 2041-1723 (ISSN-L)
- PMC
- PMC5062546
- OpenAlex
- W2530388030
- Cited by
- 697
- References
- 57
- Citations by year
- 2026: 73 · 2025: 72 · 2024: 63 · 2023: 73 · 2022: 80 · 2021: 89 · 2020: 73 · 2019: 70 · 2018: 58 · 2017: 40 · 2016: 2
- FWCI
- 32.52
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- cc-by
- creativecommons.org/licenses/by/4.0 (tdm)
- creativecommons.org/licenses/by/4.0 (vor)
- Locations
- Nature Communications (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Research at the University of Copenhagen (University of Copenhagen) (submittedVersion, other-oa)
- Funders
- Roy J. Carver Charitable Trust
- National Institutes of Health
- Directorate for Biological Sciences
- Biotechnology and Biological Sciences Research Council (BB/N001842/1)
- National Institute on Alcohol Abuse and Alcoholism (R21AA022371)
- National Heart, Lung, and Blood Institute (R01HL108379)
- National Institute of General Medical Sciences (T32GM008629)
- Topics
- Health Sciences › Medicine › Geriatrics and Gerontology › Sirtuins and Resveratrol in Medicine
- Health Sciences › Nursing › Nutrition and Dietetics › Folate and B Vitamins Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Biochemical and Molecular Research
- Keywords
- nicotinamide riboside, NAD+ metabolism, oral bioavailability, pharmacokinetics, nicotinic acid, nicotinamide, dose-dependent effects
- MeSH terms
- Administration, Oral, Animals, Biological Availability, Humans, Leukocytes, Mononuclear, Liver, Male, Mice, Inbred C57BL, Middle Aged, NAD, Niacinamide, Pyridinium Compounds, Vitamins, Biomarkers, Metabolome
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.